Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: A propensity score matching and landmark analyses

被引:11
|
作者
Shi, Zhenguo [1 ,2 ]
Zhu, Xiaojuan [2 ]
Ke, Shaobo [1 ]
Qiu, Hu [1 ]
Cai, Gaoke [1 ]
Zhangcai, Yutian [1 ]
Chen, Yongshun [1 ]
机构
[1] Wuhan Univ, Dept Clin Oncol, Renmin Hosp, Wuhan, Peoples R China
[2] Henan Univ Sci & Technol, Dept Oncol, Affiliated Hosp 1, Luoyang, Peoples R China
基金
中国国家自然科学基金;
关键词
Elderly patients; Synchronous oligometastatic esophageal; squamous cell carcinoma; Concurrent chemoradiotherapy; Survival; Nomogram; CLINICOPATHOLOGICAL CHARACTERISTICS; NEOADJUVANT CHEMORADIOTHERAPY; RADIATION-THERAPY; CANCER; RADIOTHERAPY; ONCOLOGY; CHEMOTHERAPY; MANAGEMENT; OUTCOMES; DISEASE;
D O I
10.1016/j.radonc.2021.09.033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the potential benefits of concurrent chemoradiotherapy (CCRT), and to establish a nomogram for predicting survival outcomes of elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma (SOEC). Materials and methods: This study eventually enrolled 314 elderly patients who initially diagnosed with SOEC from two centers. Treatment responses and outcomes of 151 patients receiving CCRT and 163 patients undergoing chemotherapy alone (CT) were compared. Propensity score matching and landmark analyses were performed to control potential confounding factors. A nomogram was established on the basis of the Cox regression model. Results: After a median follow-up of 42.3 months, CCRT was superior to CT alone in objective response rate (ORR, 59.6% vs. 39.9%, P < 0.001), median progression-free survival (PFS, 10.0 vs. 7.2 months, P < 0.001), and median overall survival (OS, 18.5 vs. 15.6 months, P < 0.001). The propensity score matching (PSM) and landmark analyses redemonstrated the same trend (P < 0.01). On hierarchical analysis, patients with 1- 3 metastatic lesions involving one organ displayed longer median PFS (9.0 vs. 7.8 months, P = 0.008) and OS (17.8 vs. 15.2 months, P < 0.001) than those with 4-5 metastatic lesions involving 2-3 organs. The major toxicities of grade III or higher for CCRT included leukocytopenia (23.2%), radiation esophagitis (7.3%), and radiation pneumonitis (8.6%). Cox multivariate analysis showed that the number of metastatic lesions (P = 0.012) and tumor response (P < 0.001) were independent prognostic factors associated with OS. A nomogram was established by incorporating the number of metastatic lesions and tumor response, with a concordance index of 0.743 after internal cross-validation. Calibration curves and decision curve analysis confirmed that nomogram had a favorable predictive value for individualized survival. Conclusions: Compared with CT alone, CCRT exhibited superior efficacy and acceptable toxicity in the first line treatment for elderly patients with SOEC. The current study supports the oligometastatic definition of <3 metastatic lesions involving one organ for esophageal cancer patients. The constructed nomogram can effectively predict the individualized survival. (c) 2021 Elsevier B.V. All rights reserved. Radiotherapy and Oncology 164 (2021) 236-244
引用
收藏
页码:236 / 244
页数:9
相关论文
共 50 条
  • [1] Evaluation of Concurrent Chemoradiotherapy for Survival Outcomes in Patients With Synchronous Oligometastatic Esophageal Squamous Cell Carcinoma
    Shi, Zhenguo
    Zhu, Xiaojuan
    Ruan, Changli
    Wei, Gang
    Li, Jiaojiao
    Qiu, Hu
    Gao, Lijuan
    Cai, Gaoke
    Zhangcai, Yutian
    Li, Bin
    Wang, Jing
    Gong, Yi
    Chen, Jiamei
    Zhao, Wensi
    Wu, Yong
    Ke, Shaobo
    Chen, Yongshun
    JAMA NETWORK OPEN, 2022, 5 (12) : E2244619
  • [2] Overall survival, locoregional recurrence, and distant metastasis of definitive concurrent chemoradiotherapy for cervical squamous cell carcinoma and adenocarcinoma: before and after propensity score matching analysis of a cohort study
    Zhang, Jiaqiang
    Qin, Lei
    Chen, Ho-Min
    Hsu, Han-Chuan
    Chuang, Chih-Chi
    Chen, Dar
    Wu, Szu-Yuan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (06): : 1808 - +
  • [3] Propensity score analysis comparing survival between definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
    Chang, Yi-Lin
    Cheng, Ya-Fu
    Chen, Hui-Shan
    Wu, Siao-Chi
    Hung, Wei-Heng
    Chen, Heng-Chung
    Huang, Chang-Lun
    Cheng, Ching-Yuan
    Wang, Bing-Yen
    PLOS ONE, 2022, 17 (10):
  • [4] Is There a Benefit in Receiving Concurrent Chemoradiotherapy for Elderly Patients with Inoperable Thoracic Esophageal Squamous Cell Carcinoma?
    Zhang, Peng
    Xi, Mian
    Zhao, Lei
    Shen, Jing-Xian
    Li, Qiao-Qiao
    He, Li-Ru
    Liu, Shi-Liang
    Liu, Meng-Zhong
    PLOS ONE, 2014, 9 (08):
  • [5] Treatment Outcomes and the Safety of Chemoradiotherapy With High-Dose CDDP for Elderly Patients With Head and Neck Squamous Cell Carcinoma: A Propensity Score Matching Study
    Omata, Jo
    Ueki, Yushi
    Takahashi, Takeshi
    Shodo, Ryusuke
    Yamazaki, Keisuke
    Saijo, Kohei
    Ota, Hisayuki
    Togashi, Takafumi
    Sato, Yuichiro
    Horii, Arata
    FRONTIERS IN SURGERY, 2021, 8
  • [6] Radiotherapy improves the survival of patients with metastatic esophageal squamous cell carcinoma: a propensity score matched analysis of Surveillance, Epidemiology, and End Results database
    Zhang, R.
    Jia, M.
    Li, P.
    Han, J.
    Huang, K.
    Li, Q.
    Qiao, Y.
    Xu, T.
    Ruan, P.
    Hu, Q.
    Fan, G.
    Song, Q.
    Fu, Z.
    DISEASES OF THE ESOPHAGUS, 2019, 32 (01)
  • [7] Statin Use During Concurrent Chemoradiotherapy With Improved Survival Outcomes in Esophageal Squamous Cell Carcinoma: A Propensity Score- Matched Nationwide Cohort Study
    Chen, Wan-Ming
    Yu, Ying-Hui
    Chen, Mingchih
    Shia, Ben-Chang
    Wu, Szu-Yuan
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (08) : 1082 - 1093
  • [8] Maintenance chemotherapy for esophageal squamous cell carcinoma after standard concurrent chemoradiotherapy: a national propensity score matching cohort study
    Tseng, Szu-Wen
    Chen, Wan-Ming
    Jao, An-Tzu
    Chen, Mingchih
    Shia, Ben-Chang
    Wu, Szu-Yuan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (05): : 2300 - 2312
  • [9] The survival impact of postoperative complications after curative resection in patients with esophageal squamous cell carcinoma: propensity score-matching analysis
    Yamamoto, Manabu
    Shimokawa, Mototsugu
    Yoshida, Daisuke
    Yamaguchi, Shohei
    Ohta, Mitsuhiko
    Egashira, Akinori
    Ikebe, Masahiko
    Morita, Masaru
    Toh, Yasushi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (05) : 1351 - 1360
  • [10] Postoperative Concurrent Chemoradiotherapy versus Postoperative Radiotherapy Alone for Larynx Squamous Cell Carcinoma Patients with Lymphovascular Invasion: A Propensity Score Matching Study
    Yu, Shuting
    Zhu, Yingying
    Shi, Xiaohua
    Hu, Ke
    Bai, Chunmei
    Diao, Wenwen
    Zhu, Xiaoli
    Gao, Zhiqiang
    Chen, Xingming
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 4063 - 4071